Neuroblastoma trials in Sweden

4 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma

  Where

  Solna

  Age

  18 months to 64 years

  People

  24 worldwide

  Run by

  Jakob Stenman

  See details and how to joinNCT04903899 · EU 2023-503684-42-00
• Phase 1/2Taking people
  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Where

  Gothenburg

  Age

  6 months to 25 years

  People

  90 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06395103 · EU 2023-507178-41-00
• Phase 1/2Taking people
  A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

  Where

  Gothenburg, Stockholm

  Age

  1 year to 64 years

  People

  160 worldwide

  Run by

  University of Birmingham

  See details and how to joinNCT07334301 · EU 2024-516115-24-00
• Phase 3Taking people
  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  Where

  Gothenburg, Linkoping, Lund, Stockholm, Umeå, Uppsala

  Age

  Up to 21 years

  People

  800 worldwide

  Run by

  Gustave Roussy, Cancer Campus, Grand Paris

  See details and how to joinNCT04221035 · EU 2024-514917-36-00